Published on 2/13/2015 in the Prospect News Structured Products Daily.
New Issue: UBS prices $205,000 trigger return optimization securities linked to Gilead Sciences
New York, Feb. 13 – UBS AG, London Branch priced $205,000 of trigger return optimization securities due Feb. 21, 2017 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
If Gilead Sciences stock closes at or above the initial price, the payout at maturity will be par plus three times any gain in common stock of Gilead Sciences capped at 38.25%.
Investors will share in any losses.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger return optimization securities
|
Underlying stock: | Gilead Sciences, Inc. (Nasdaq: GILD)
|
Amount: | $205,000
|
Maturity: | Feb. 21, 2017
|
Coupon: | 0%
|
Price: | Par of $10
|
Payout at maturity: | Par plus three times any gain in common stock of Gilead Sciences, capped at 38.25%; otherwise, exposure to any losses
|
Initial share price: | $101.90
|
Pricing date: | Feb. 13
|
Settlement date: | Feb. 19
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 2%
|
Cusip: | 90274M309
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.